Detalhe da pesquisa
1.
RWD Domain as an E2 (Ubc9)-Interaction Module.
J Biol Chem
; 290(27): 16550-9, 2015 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25918163
2.
Critical Non-Covalent Binding Intermediate for an Allosteric Covalent Inhibitor of SUMO E1.
J Phys Chem Lett
; 14(11): 2792-2799, 2023 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898086
3.
Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme.
Cell Chem Biol
; 26(2): 278-288.e6, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30581133
4.
Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme.
Nat Commun
; 9(1): 5145, 2018 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514846
5.
Observation of an E2 (Ubc9)-homodimer by crystallography.
Data Brief
; 7: 195-200, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27408909
6.
A Novel Class of HIV-1 Antiviral Agents Targeting HIV via a SUMOylation-Dependent Mechanism.
Sci Rep
; 5: 17808, 2015 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26643614
7.
Design of high-throughput screening assays and identification of a SUMO1-specific small molecule chemotype targeting the SUMO-interacting motif-binding surface.
ACS Comb Sci
; 17(4): 239-46, 2015 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25719760